Supporting Investors and Industry Leaders.
MycoStories was established after extensive engagement with leaders in the fungi space, revealing common challenges across the industry—from market research and due diligence to technical and scientific insights.
Our mission is to equip investors and industry leaders with the expertise and strategic connections essential for identifying high-potential opportunities and fostering sustainable growth within the fungi innovation sector.
Market Research &
Due Dilligence
Make informed investment or commercial decisions by accessing comprehensive insights into industries where fungi biotechnologies are driving innovation—from food and materials to agriculture, forestry, and health.
We continuously scan the market for the latest research, innovations, and entrepreneurial trends, supported by our extensive knowledge base of over 600 companies and 100 research institutions working with fungi.
Scientific Advisory
Outsource your DNA barcoding, bioprospecting, and bioinformatics.
We provide genetic identification of fungi, phylogenetic analysis, and whole genome sequencing. Additionally, we help you source and isolate wild-type strains, conduct metabolic and phenotype assays, and build libraries for GMO applications.
Technical Advisory
Streamline lab operations and accelerate innovation through advanced automation and tailored R&D.
We specialise in configuring lab automation, creating robotic workflows, and scaling operations with custom-coded solutions. Additionally, we offer biotech-focused R&D, proof-of-concept development, and contract software services to drive your research forward efficiently.
Promotion & Sponsorships
Reach a fast-growing community of 35,000 fungi innovation enthusiasts, with a monthly reach of over 500,000 through a targeted promotional partnership highlighting your organisation’s vision and product/services(s).
How can we help?
A word from our partners.
Thibaul Fournel | Founder, Koz
"Working with MycoStories was instrumental to achieving breakthroughs in our 2nd generation mycelium composite prototypes and unlocking subsequent funding."